Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Current Assets

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Net Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Current Assets (Including Current Investments) ₹4,923 Cr₹3,328 Cr₹1,609 Cr₹3,877 Cr₹3,593 Cr

What is the latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS is ₹4,923 Cr based on Mar2026 Consolidated results.
Year Net Current Assets
Mar2026₹4,923 Cr
Mar2025₹3,328 Cr
Mar2024₹1,609 Cr
Mar2023₹3,877 Cr
Mar2022₹3,593 Cr

How is Net Current Assets of GLENMARK PHARMACEUTICALS Trending?

Years Net Current Assets % Change
Mar2026 ₹4,923 Cr
47.92
Mar2025 ₹3,328 Cr
106.80
Mar2024 ₹1,609 Cr
-58.49
Mar2023 ₹3,877 Cr
7.92
Mar2022 ₹3,593 Cr -

Compare Net Current Assets of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹74,726.6 Cr 0.7% 21.3% 40.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹452,299.0 Cr 1% 7.5% 7.9% Stock Analytics
DIVIS LABORATORIES ₹297,325.0 Cr 0.8% 22.8% 71.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹178,727.0 Cr 0.2% 1.9% 20.9% Stock Analytics
DR REDDYS LABORATORIES ₹116,145.0 Cr 0.8% 12.2% 12.3% Stock Analytics
CIPLA ₹114,312.0 Cr 1.5% 6.4% -7.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

0.7%

21.3%

40.5%

SENSEX

2.9%

13.9%

-0.8%


You may also like the below Video Courses